85 related articles for article (PubMed ID: 18709729)
1. [Change in serum concentration of itraconazole according to its dosage form].
Chineno T
Jpn J Antibiot; 2008 Apr; 61(2):92-4. PubMed ID: 18709729
[No Abstract] [Full Text] [Related]
2. Serum itraconazole concentrations and clinical responses in Candida-associated denture stomatitis patients treated with itraconazole solution and itraconazole capsules.
Cross LJ; Bagg J; Oliver D; Warnock D
J Antimicrob Chemother; 2000 Jan; 45(1):95-9. PubMed ID: 10629018
[TBL] [Abstract][Full Text] [Related]
3. Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis.
Cartledge JD; Midgely J; Gazzard BG
J Clin Pathol; 1997 Jun; 50(6):477-80. PubMed ID: 9378812
[TBL] [Abstract][Full Text] [Related]
4. Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
Myoken Y; Sugata T; Kyo T; Fujihara M; Mikami Y
J Periodontol; 2002 Jan; 73(1):33-8. PubMed ID: 11846198
[TBL] [Abstract][Full Text] [Related]
5. [Development of treatment adherence by jellification of itraconazole oral solution].
Wada H; Tanabe S; Ichikawa K; Sano F; Kubo Y; Matsuhashi Y; Nakanishi H; Tasaka T; Sugihara T
Jpn J Antibiot; 2009 Feb; 62(1):17-25. PubMed ID: 19378767
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of itraconazole injections for treatment of febrile neutropenia].
Saito T; Inoue Y; Kato A; Takimoto M; Suzuki T; Iyoshi N; Arai T; Shibuya Y; Suzuki Y; Kato M; Takahashi M; Miura I; Ogawa K
Jpn J Antibiot; 2008 Apr; 61(2):95-8. PubMed ID: 18709730
[No Abstract] [Full Text] [Related]
7. Itraconazole solution for oral yeast infections.
TreatmentUpdate; 1998 May; 10(3):2-3. PubMed ID: 11365439
[TBL] [Abstract][Full Text] [Related]
8. Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl-beta-cyclodextrin oral solution or coated-pellet capsules.
Glasmacher A; Hahn C; Molitor E; Marklein G; Sauerbruch T; Schmidt-Wolf IG
Mycoses; 1999; 42(11-12):591-600. PubMed ID: 10680434
[TBL] [Abstract][Full Text] [Related]
9. Candidiasis at ICAAC.
Barr D; Smart T
GMHC Treat Issues; 1995 Oct; 9(10):13. PubMed ID: 11362914
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological, pharmacokinetic, and clinical profile of itraconazole oral solution (ITRIZOLE Oral Solution 1%)].
Otani H; Inoue K; Shiota T; Suzuki Y; Nomura S; Harada Y; Ishibashi H; Abe S; Uchida K; Yamaguchi H; Torii S
Nihon Yakurigaku Zasshi; 2007 Jul; 130(1):69-76. PubMed ID: 17634684
[No Abstract] [Full Text] [Related]
11. Oral administration of itraconazole solution has superior efficacy in experimental oral and oesophageal candidiasis in mice than its intragastric administration.
Ishibashi H; Uchida K; Nishiyama Y; Yamaguchi H; Abe S
J Antimicrob Chemother; 2007 Feb; 59(2):317-20. PubMed ID: 17107970
[TBL] [Abstract][Full Text] [Related]
12. Itraconazole disposition after single oral and intravenous and multiple oral dosing in healthy cats.
Boothe DM; Herring I; Calvin J; Way N; Dvorak J
Am J Vet Res; 1997 Aug; 58(8):872-7. PubMed ID: 9256973
[TBL] [Abstract][Full Text] [Related]
13. Correlation of in vitro activity and in vivo efficacy of itraconazole intravenous and oral solubilized formulations by testing Candida strains with various itraconazole susceptibilities in a murine invasive infection.
Uchida K; Shimogawara K; Yamaguchi H
J Antimicrob Chemother; 2011 Mar; 66(3):626-34. PubMed ID: 21172782
[TBL] [Abstract][Full Text] [Related]
14. Summaries for patients. Preventing fungal infections in patients with stem-cell transplants.
Ann Intern Med; 2003 May; 138(9):I37. PubMed ID: 12729449
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations.
Buchanan CM; Buchanan NL; Edgar KJ; Klein S; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
J Pharm Sci; 2007 Nov; 96(11):3100-16. PubMed ID: 17712849
[TBL] [Abstract][Full Text] [Related]
16. Azole resistance in yeasts.
Craig JM; Nash CL; Kinghorn GR
Ann Pharmacother; 1997 Feb; 31(2):255. PubMed ID: 9034436
[No Abstract] [Full Text] [Related]
17. The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea.
Kim JS; Cheong JW; Kim YK; Park J; Mun YC; Kang HJ; Yi HG; Lee JH; Kim YS; Ryoo HM; Kim SH; Kim HY; Kim JY; Lee DG; Kim HG; Kim H; Joo YD; Min YH
Ann Hematol; 2014 Jan; 93(1):33-42. PubMed ID: 23807252
[TBL] [Abstract][Full Text] [Related]
18. Nanocrystal-based per-oral itraconazole delivery: superior in vitro dissolution enhancement versus Sporanox® is not realized in in vivo drug absorption.
Sarnes A; Kovalainen M; Häkkinen MR; Laaksonen T; Laru J; Kiesvaara J; Ilkka J; Oksala O; Rönkkö S; Järvinen K; Hirvonen J; Peltonen L
J Control Release; 2014 Apr; 180():109-16. PubMed ID: 24566254
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of intravascular itraconazole in the American horseshoe crab (Limulus polyphemus).
Allender MC; Schumacher J; Milam J; George R; Cox S; Martín-Jiménez T
J Vet Pharmacol Ther; 2008 Feb; 31(1):83-6. PubMed ID: 18177324
[No Abstract] [Full Text] [Related]
20. Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.
Caillot D; Bassaris H; McGeer A; Arthur C; Prentice HG; Seifert W; De Beule K
Clin Infect Dis; 2001 Oct; 33(8):e83-90. PubMed ID: 11550120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
